Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  testicular cancer
Stage/Subtype:  testicular cancer
Results 1-25 of 29 for your search:
Start Over
Combination Chemotherapy and Fixed or Flexible Administration of Filgrastim in Treating Younger Patients With Cancer
Status: Active
Phase: Phase III
Type: Treatment
Age: 1 to 25
Trial IDs: 2013-062, NCI-2013-02001, NCT01987596
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors
Status: Active
Phase: Phase III
Type: Treatment
Age: 14 and over
Trial IDs: A031102, NCI-2014-01696, 1407-GUCG, 2014-003930-17, PA031102_A01PAMDREVW01, NCT02375204
A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: BBI608-201, NCI-2014-01566, NCT01325441
Gemcitabine Hydrochloride, Oxaliplatin, and Paclitaxel in Treating Patients With Refractory Germ Cell Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 16 and over
Trial IDs: 4T-03-1, NCI-2011-01350, NCT00183820
Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors
Status: Active
Phase: Phase II
Type: Treatment
Age: 10 to 69
Trial IDs: MT2005-21, NCI-2010-01700, 2006LS032, UMN-2006LS032, UMN-MT2005-21, UMN-0608M90586, NCT00432094
High-Dose Chemotherapy, Bevacizumab and Stem Cell Transplant in Treating Patients with Recurrent Germ Cell Tumors
Status: Active
Phase: Phase II
Type: Treatment
Age: 12 to 65
Trial IDs: 2008-0378, NCI-2011-01631, NCT00936936
Proton Radiation Therapy in Treating Patients with Stage I-II Testicular Seminoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: UPCC #17811, NCI-2012-00343, 814388, NCT01557790
Fosaprepitant Dimeglumine, 5HT3 Receptor Antagonists, and Dexamethasone in Reducing Nausea and Vomiting in Patients with Germ Cell Tumors Undergoing Chemotherapy with Cisplatin
Status: Active
Phase: Phase II
Type: Supportive care
Age: 15 and over
Trial IDs: QL12-153, NCI-2013-00278, 1211010041, 1211010041R001, HOG QL12-153, NCT01736917
Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: IUCRO-0403, NCI-2013-00510, 1301010501, NCT01808534
Retroperitoneal Lymph Node Dissection in Treating Patients with Stage I-IIA Testicular Seminoma
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 16 and over
Trial IDs: 4T-14-1, NCI-2015-01177, HS-15-00246, NCT02537548
Pembrolizumab in Treating Patients with Rare Solid Tumors That Cannot Be Removed by Surgery or are Metastatic
Status: Not yet active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2015-0948, NCI-2016-00545, NCT02721732
Vaccine Therapy with ISCOMATRIX Adjuvant, Cyclophosphamide, and Celecoxib in Treating Patients with Sarcomas, Melanomas, Germ Cell Tumors, or Epithelial Malignancies with Lung, Pleura, or Mediastinal Metastases Undergoing Surgery
Status: Temporarily closed
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 11-C-0148, NCI-2013-01488, 110148, 312743, P10786, NCT01341496
Veliparib, Paclitaxel, and Carboplatin in Treating Patients with Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: UPCI 10-115, NCI-2011-02500, CDR0000700997, 8808, NCT01366144
Donor Hematopoietic Stem Cell Transplant in Treating Young Patients with Relapsed or Refractory Solid Tumors or Lymphomas
Status: Active
Phase: Phase I
Type: Treatment
Age: 2 to 21
Trial IDs: RADIANT, NCI-2012-00588, NCT01625351
Donor Lymphocyte Infusion in Treating Patients Previously Treated with Donor Stem Cell Transplant
Status: Active
Phase: Phase I
Type: Supportive care
Age: 18 and over
Trial IDs: Pro00003975, NCI-2013-00567, NCT01627275
NAC to Prevent Cisplatin-induced Hearing Loss
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Age: 21 and under
Trial IDs: CCI-14-00270, NCI-2016-00542, NCT02094625
Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: PM60184-A-003-14, NCI-2015-01510, 2014-002943-16, NCT02533674
Collecting and Storing Tissue From Young Patients With Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Tissue collection/Repository
Age: 21 and under
Trial IDs: ABTR04B1, NCI-2009-00326, CDR0000478867, COG-ABTR04B1, NCT00898755
Informed Consent to Enroll Younger Patients with Newly Diagnosed Cancer in the Childhood Cancer Research Network
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Health services research, Treatment
Age: 18 and under
Trial IDs: ACCRN07, NCI-2009-00331, CDR0000069496, 10-C-0111, NCT01117168
DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Age: 19 and under
Trial IDs: AEPI10N1, NCI-2011-03464, CDR0000711070, COG-AEPI10N1, NCT01434355
Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal Tumors
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Tissue collection/Repository
Age: Not specified
Trial IDs: ARAR12B2, NCI-2012-00721, CDR0000730091, COG-ARAR12B2, NCT01572467
Magnetic Resonance Imaging in Planning Radiation Therapy in Patients with Liver, Brain, Head and Neck, or Pelvic Cancer
Status: Active
Phase: No phase specified
Type: Diagnostic
Age: 18 and over
Trial IDs: UMCC 2012.113, NCI-2012-02750, HUM00068061, NCT02045381
Natural History Study of Cancer Susceptibility in Patients with Fanconi Anemia, Inherited Bone Marrow Failure Syndromes, and Family Members
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Age: Not specified
Trial IDs: 02-C-0052, NCI-2013-02026, CGB 7130, NCT00056121, NCT00027274
Etiologic Study of Familial Testicular Cancer
Status: Active
Phase: No phase specified
Type: Genetics, Natural history/Epidemiology
Age: 12 and over
Trial IDs: 02-C-0178, NCI-2013-02030, NCT00039598, NCT00034424
Start Over